Analysis of Risk Factors for Recurrence and Effective Adjuvant Therapy in Patients with Endometrial Cancer
-
- GOTO,Tomoko
- Department of Obstetrics and Gynecology, National Defense Medical College
-
- TAKANO,Masashi
- Department of Obstetrics and Gynecology, National Defense Medical College
-
- KITA,Tsunekazu
- Department of Obstetrics and Gynecology, National Defense Medical College
-
- KIKUCHI,Yoshihiro
- Department of Obstetrics and Gynecology, National Defense Medical College
Bibliographic Information
- Other Title
-
- 子宮体癌術後の再発危険因子の解析と有効な補助療法に関する検討
Search this article
Description
Objective : The aim of this study was to explore risk factors for recurrence and effective adjuvant therapy in endometrial cancer. Methods : Between 1985 and 1999, 170 patients with uterine endometrial cancer received initial therapy at the National Defense Medical College Hospital. We retrospectively analyzed risk factors including histopathological features, operative procedures, adjuvant therapies and surgical staging. Results : Althouth the prognosis in stage I and II patients was fairly good, recurrences were observed in patients with stage Ib or worse. Vagina walls were the frequent site of recurrence. About a half of relapses which occurred within seven months after surgery were observed during adjuvant chemotherapy. Multivariate analysis revealed that myometrial invasion(p=0.0231)was the only risk factor for recurrence. Although the prognosis in stage III and IV patients was generally poor, serosal invasion in stage III disease seemed to be an important risk factor. With regard to adjuvant therapy in stage I-III patients who could receive optimal cytoreductive surgery, the risk of recurrence was significantly(p=0.0127)lower in patients receiving radiation therapy than in those receiving chemotherapy including platinum agents. Conclusion : The data suggested that in stage I-III patients with optimal cytoreductive surgery, myometrial invasion is an independent risk factor for recurrence and radiation therapy is more effective than chemotherapy as adjuvant therapy.
Journal
-
- 日本産科婦人科學會雜誌
-
日本産科婦人科學會雜誌 54 (1), 17-22, 2002-01-01
日本産科婦人科学会
- Tweet
Details 詳細情報について
-
- CRID
- 1541698620244474880
-
- NII Article ID
- 110002182544
-
- NII Book ID
- AN00190060
-
- Text Lang
- ja
-
- Data Source
-
- NDL Digital Collections (NII-ELS)
- CiNii Articles